Search - tctmd.com

Displaying 201 - 220 of 389

Sort: Relevancy | Date

News Daily News

New Guideline Aims to Standardize Anticoagulation During Cardiopulmonary Bypass

Todd Neale

January 19, 2018

News Daily News

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

Caitlin E. Cox

January 11, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Conference News AHA 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

Todd Neale

November 16, 2017

News Industry News

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

November 14, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

Presenter: Kurt Huber, Jamil Abdalla Saad, Kara Denby, MD

October 31, 2017

Presentation TCT 2017

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD

October 31, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Conference News ESC 2017

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

Todd Neale

September 01, 2017

News Conference News ESC 2017

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Todd Neale

August 27, 2017

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD

Yael L. Maxwell

June 20, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Daily News

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Todd Neale

May 22, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

Advertisement

New Guideline Aims to Standardize Anticoagulation During Cardiopulmonary Bypass

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

TCTMD’s Top 10 Most Popular Stories for December 2017

RE-DUAL PCI Findings Consistent Across Key Subgroups

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content